Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Newton, M.
Right arrow Articles by Gauthier, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Newton, M.
Right arrow Articles by Gauthier, H.
(Chest. 1999;115:1755-1757.)
© 1999 American College of Chest Physicians

Testing for Exercise Limitation in Obstructive Lung Disease

Marc Newton , MD; Katherine A. Webb , MSc and Denis E. O'Donnell, MD, FCCP*

Queen's University Kingston, ON, Canada

To the Editor:

In their recent article, Murariu and colleagues (October 1998)1 report that exercise performance in patients with obstructive lung disease is likely linked to the degree of resting lung hyperinflation as indirectly measured by inspiratory capacity (IC). Certainly, there is increasing evidence that dynamic lung hyperinflation during exercise (as assessed by serial IC measurements) contributes to the intensity and quality of dyspnea, and thus exercise limitation in COPD.2 ,3 ,4 Furthermore, increases in dynamic IC have been shown to correlate well with improvement in dyspnea and exercise endurance following pharmacologic2 ,3 and surgical volume reduction.5 The study by Murariu and colleagues is, however, the first to claim an association between the resting IC and exercise performance in patients with obstructive lung disease (COPD and asthma).

The authors report a correlation coefficient of 0.81 (p < 0.001) between maximal exercise power output (max) and IC in 25 patients with mild COPD (FEV1, 0.68 ± 21) who had, on average, moderate exertional dyspnea (Borg 4 ± 1) and exercise curtailment max (62 ± 29% predicted). There is, however, a significant confounding factor here that the authors did not correct for: the absolute max and the IC would be expected to be linearly related, even in normal subjects. The predicted IC and max are both functions of age, sex, and height. Simply stated, taller, younger male subjects would be expected to have high max and IC, while shorter, older female subjects would have lower max and IC. In fact, predicted max is a linear equation of age, sex, and height.6 This explains the significant correlation between height and max as reported by Murariu and colleagues (correlation coefficient, 0.61; p < 0.005).

To establish a causal relationship between reduced IC and diminished max, both IC and max should be normalized and expressed as percent predicted. In their article, Murariu and coworkers provided us with the respiratory function and max data (reported as percent predicted) for all study subjects. When viewed in this way, the relationship is not as strong (Fig 1 ). In fact, the correlation coefficient is only 0.294 (p = 0.154).



View larger version (14K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1. Relationship between IC (percent predicted) and max (percent predicted) in 25 patients with obstructive airways disease, compiled from data provided by Murariu et al.1

 
In summary, it is not likely that a particular patient's exercise limitation would be strongly predicted by a single static pulmonary function test. That is not to say that lung hyperinflation, and particularly dynamic hyperinflation during exercise, is not important in dyspnea causation and exercise limitation in many patients with COPD. However, spirometric testing does not obviate the need for direct cardiopulmonary exercise testing, which remains the best and only way to accurately evaluate exercise capacity.

Correspondence to: Marc Newton, MD, Division of Respiratory and Critical Care Medicine, Queen's University, 102 Stuart St, Kingston, ON, Canada; e-mail: fmnewton@istar.ca

References

  1. Murariu, C, Ghezzo, H, Milic-Emili, J, et al (1998) Exercise limitation in obstructive lung disease. Chest 114,965-968[Abstract/Free Full Text]
  2. O'Donnell, DE, Webb, KA (1993) Exertional breathlessness in patients with chronic airflow limitation: the role of lung hyperinflation. Am Rev Respir Dis 148,1351-1357[ISI][Medline]
  3. Belman, MJ, Botnick, WC, Shin, JW (1996) Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 153,967-975[Abstract]
  4. O'Donnell, DE, Lam, M, Webb, KA (1998) Measurement of symptoms, lung hyperinflation and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158,1557-1565[Abstract/Free Full Text]
  5. Martinez, FJ, Montes de Oca, M, Whyte, RI, et al (1997) Lung-volume reduction improves dyspnea, dynamic hyperinflation and respiratory muscle function. Am J Respir Crit Care Med 155,1984-1990[Abstract]
  6. Jones, NL, Makrides, L, Hitchcock, C, et al (1985) Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis 131,700-708[ISI][Medline]

Testing for Exercise Limitation in Obstructive Lung Disease

Cristina Murariu , MD; Heberto Ghezzo , PhD; Joseph Milic-Emili , MD and Henry Gauthier, MD*

Meakins-Christie Laboratories McGill University Montreal, QC, Canada

To the Editor:

In normal subjects, there is a close association between maximal exercise power output (max) and vital capacity, the variation coefficient (r2) amounting to 0.79.1-1 Nevertheless, in our patients with obstructive lung disease (OLD), the variation coefficient of max to FVC was substantially weaker than that of inspiratory capacity (IC) (0.41 vs 0.66). Furthermore, in 21 patients with restrictive lung disease (RLD) who were included in our original manuscript, there was no significant correlation of max to IC, though their exertional dyspnea and exercise curtailment were similar to those of the OLD patients. Thus, in OLD but not RLD patients, the resting IC is a better predictor of max than either FVC or FEV1.

Although we argue that there is predictably a close association between max and IC in OLD patients because of expiratory flow limitation, we do not state that "a particular patient's exercise limitation can be strongly predicted by IC." In fact, the r2 between max and IC was only 0.66, reflecting substantial scatter of the data.

Prediction of max and IC is a nettlesome problem in old individuals, such as our OLD population. In fact, there are many predictive equations for max, each giving a different value.1-1 Furthermore, the predicted normal values of IC are obtained as the difference between predicted total lung capacity and FRC. Thus, assessment of the relationship of max (% predicted) to IC (% predicted) may be problematic, particularly in small numbers of patients with moderate exercise limitation. In 34 OLD patients with a more marked decrease in max (39% predicted on average), a significant correlation was found both between the absolute and the predicted values of max and IC, with IC being the only significant contributor to max (O. Diaz Patiño, MD, C. Lisboa, MD, J. Milic-Emili, MD; unpublished observations, July 1998).

In conclusion, we think that resting IC, the Cinderella of lung function testing, not only provides useful information about the effects of bronchodilators1-2 and surgical treatment1-3 on hyperinflation in OLD patients, but it also gives a useful estimate of a patient's exercise capacity. If the actual max in a given OLD patient is lower than that predicted by our regression equation, it is likely that the patient should benefit substantially by exercise rehabilitation because the exercise performance is probably mostly limited by mechanisms other than lung function impairment.

Correspondence to: Joseph Milic-Emili, MD, Meakins Christie Laboratories, McGill University, 3626 St. Urbain Street, Montreal QC H2X 2P2, Canada; e-mail: milic@meakins.lan.mcgill.ca

References

  1. Jones, NJ (1997) Clinical exercise testing 4th ed. ,243 WB Saunders (Philadelphia, PA).
  2. Tantucci, C, Duguet, A, Similowski, T, et al (1998) Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients. Eur Respir J 12,799-804[Abstract]
  3. Boczkowski, J, Murciano, D, Pichot, M-H, et al (1997) Expiratory flow limitation in stable asthmatic patients during resting breathing. Am J Respir Crit Care Med 156,752-757[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Newton, M.
Right arrow Articles by Gauthier, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Newton, M.
Right arrow Articles by Gauthier, H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS